Traditional management of invasive cervical cancer

被引：23

作者：

Holtz, DO

Dunton, C

机构：

[1] Albert Einstein Med Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19141 USA

[2] Thomas Jefferson Univ, Jefferson Med Coll, Dept Obstet & Gynecol, Philadelphia, PA 19107 USA

来源：

OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA | 2002年 / 29卷 / 04期

关键词：

D O I：

10.1016/S0889-8545(02)00023-2

中图分类号：

R71 [妇产科学];

学科分类号：

100211 [妇产科学];

摘要：

Cervical cancer continues to be one of the most frequent and deadly cancers affecting women worldwide. In developed countries with implemented screening programs, the incidence of this cancer is markedly decreased, while the incidence of cervical intraepithelial neoplasia (CIN) rises. Effective treatment of CIN decreases the incidence of and the mortality from cervical cancer. In the United States in 2001, it is estimated that there will be approximately 15,000 cases of and 4,000 deaths from invasive cervical cancer. This article reviews the current state-of-the art of treatment in the United States for cervical cancer.

引用

收藏

页码：645 / +

页数：14

相关论文

共 58 条

[1]

OVARIAN TRANSPOSITION IN CERVICAL-CANCER [J].

ANDERSON, B ;

LAPOLLA, J ;

TURNER, D ;

CHAPMAN, G ;

BULLER, R .

GYNECOLOGIC ONCOLOGY, 1993, 49 (02) :206-214

[2]

[Anonymous], CLIN GYNECOLOGIC ONC

[3]

RANDOMIZED TRIAL OF 3 CISPLATIN DOSE SCHEDULES IN SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].

BONOMI, P ;

BLESSING, JA ;

STEHMAN, FB ;

DISAIA, PJ ;

WALTON, L ;

MAJOR, FJ .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (08) :1079-1085

[4]

BRUNSCHWIG A, 1948, CANCER, V1, P177, DOI 10.1002/1097-0142(194807)1:2<177::AID-CNCR2820010203>3.0.CO

[5]

2-A

[6]

Prognostic factors of primary adenocarcinoma of the uterine cervix [J].

Chen, RJ ;

Chang, DY ;

Yen, ML ;

Lee, EF ;

Huang, SC ;

Chow, SN ;

Hsieh, CY .

GYNECOLOGIC ONCOLOGY, 1998, 69 (02) :157-164

[7]

WIDESPREAD LYMPH-NODE METASTASES IN A PATIENT WITH MICROINVASIVE CERVICAL-CARCINOMA [J].

COLLINS, HS ;

BURKE, TW ;

WOODWARD, JE ;

SPURLOCK, JW ;

HELLER, PB .

GYNECOLOGIC ONCOLOGY, 1989, 34 (02) :219-221

[8]

PROSPECTIVE SURGICAL PATHOLOGICAL-STUDY OF DISEASE-FREE INTERVAL IN PATIENTS WITH STAGE IB SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].

DELGADO, G ;

BUNDY, B ;

ZAINO, R ;

SEVIN, BU ;

CREASMAN, WT ;

MAJOR, F .

GYNECOLOGIC ONCOLOGY, 1990, 38 (03) :352-357

[9]

A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma [J].

Dueñas-Gonzalez, A ;

Lopez-Graniel, C ;

Gonzalez, A ;

Reyes, M ;

Mota, A ;

Muñoz, D ;

Solorza, G ;

Hinojosa, LM ;

Guadarrama, R ;

Florentino, R ;

Mohar, A ;

Meléndez, J ;

Maldonado, V ;

Chanona, J ;

Robles, E ;

De la Garza, J .

ANNALS OF ONCOLOGY, 2001, 12 (04) :541-547

[10]

NEOADJUVANT CHEMOTHERAPY WITH VINCRISTINE AND CISPLATIN FOLLOWED BY RADICAL HYSTERECTOMY AND PELVIC LYMPHADENECTOMY FOR FIGO STAGE IB BULKY CERVICAL-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP PILOT-STUDY [J].

EDDY, GL ;

MANETTA, A ;

ALVAREZ, RD ;

WILLIAMS, L ;

CREASMAN, WT .

GYNECOLOGIC ONCOLOGY, 1995, 57 (03) :412-416

← 1 2 3 4 5 6 →